{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T06:12:47Z","timestamp":1765260767500,"version":"3.46.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Breast cancer is one of the most common malignancies among women, and more than 90% of breast cancer-related deaths attributed to metastasis. Cutaneous metastases are relatively uncommon, and scalp involvement is exceedingly rare. Because of its atypical clinical presentation, scalp metastasis is often recognized and diagnosed only after a delay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We report the case of a 45-year-old woman diagnosed with invasive ductal carcinoma (IDC) of the right breast with ipsilateral axillary lymph node involvement (clinical stage cT4bN3M0). The patient received six cycles of neoadjuvant chemotherapy and achieved a partial response (PR) according to RECIST 1.1 criteria. Subsequently, she underwent a right simple mastectomy with axillary lymph node dissection. Pathology demonstrated a Miller\u2013Payne grade 3 response, with metastases identified in all 13 dissected axillary lymph nodes (13\/13). Immunohistochemistry (IHC) revealed estrogen receptors (ER) and progesterone receptors (PR) positivity, human epidermal growth factor receptor-2 (HER2) expression of 0, and Ki-67 expression of 20%. She subsequently received adjuvant radiotherapy and endocrine therapy. Surveillance imaging during follow-up showed no evidence of recurrence or distant metastasis. In December 2023, the patient developed a painless, round, skin-colored nodule on the left frontal scalp, accompanied by diffuse right periorbital edema and headache. Over the following year, she was evaluated in dermatology, neurosurgery, and oncology clinics. However, breast cancer metastasis was not initially suspected, resulting in misdiagnosis and delayed treatment. In April 2025, fine-needle aspiration of the scalp nodule confirmed metastatic carcinoma. IHC showed ER and PR positivity, HER2 expression of 1+, and Ki-67 expression of 35%. No additional metastatic lesions were identified. The patient was started on systemic therapy with fulvestrant plus dalpiciclib, and after four cycles, she achieved marked regression of the scalp lesion along with resolution of periorbital edema. The most recent examination, however, detected meningeal and calvarial metastases. Consequently, the patient received localized radiotherapy to these sites while continuing the original treatment protocol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case highlights the diagnostic challenges of atypical scalp metastases in breast cancer and underscores the importance of early detection and prompt initiation of comprehensive treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2025.1709244","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T05:13:05Z","timestamp":1765257185000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Solitary scalp metastasis after surgery for invasive ductal carcinoma of the breast"],"prefix":"10.3389","volume":"15","author":[{"given":"Chong","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiejun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2021203476","article-title":"Breast cancer mortality rates have stopped declining in U.S. Women younger than 40 years","volume":"299","author":"Hendrick","year":"2021","journal-title":"Radiology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.3390\/cancers14081881","article-title":"Stress in metastatic breast cancer: to the bone and beyond","volume":"14","author":"Louren\u00e7o","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"15625","DOI":"10.3390\/ijms242115625","article-title":"Organ-specificity of breast cancer metastasis","volume":"24","author":"Ibragimova","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(93)70173-Q","article-title":"Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients","volume":"29","author":"Lookingbill","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3390\/cancers14051151","article-title":"Differences in the molecular profile between primary breast carcinomas and their cutaneous metastases","volume":"14","author":"Gonz\u00e1lez-Mart\u00ednez","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.01.040","article-title":"Deciphering breast cancer: from biology to the clinic","volume":"186","author":"Nolan","year":"2023","journal-title":"Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S456532","article-title":"Scalp metastasis after breast cancer surgery: A case report","volume":"17","author":"Wu","year":"2024","journal-title":"Onco Targets Ther"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"5416","DOI":"10.3390\/cancers13215416","article-title":"Clinical, pathological, and molecular features of breast carcinoma cutaneous metastasis","volume":"13","author":"Gonz\u00e1lez-Mart\u00ednez","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2010.01365.x","article-title":"Cutaneous manifestations of breast carcinoma","volume":"23","author":"De Giorgi","year":"2010","journal-title":"Dermatol Ther"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e93299","DOI":"10.7759\/cureus.93299","article-title":"A scalp tumor revealing metastatic breast cancer: A case report","volume":"17","author":"Mohamed","year":"2025","journal-title":"Cureus"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41698-018-0047-0","article-title":"Organotropism: new insights into molecular mechanisms of breast cancer metastasis","volume":"2","author":"Chen","year":"2018","journal-title":"NPJ Precis Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1361333","article-title":"Case report: Unusual breast cancer metastasis manifesting as a scalp lesion in a patient with invasive lobular carcinoma","volume":"14","author":"Koh","year":"2024","journal-title":"Front Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13256-023-03928-8","article-title":"Breast cancer with scalp metastases: a case report","volume":"17","author":"Abdulraheem","year":"2023","journal-title":"J Med Case Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2020.01.230","article-title":"An unusual case of scalp metastasis from breast cancer","volume":"137","author":"Liu","year":"2020","journal-title":"World Neurosurg"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1382415","article-title":"Case report: Advanced breast cancer with scalp metastases: a report of two cases","volume":"14","author":"Yu","year":"2024","journal-title":"Front Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e77187","DOI":"10.7759\/cureus.77187","article-title":"Cutaneous scalp metastasis from mammary ductal carcinoma","volume":"17","author":"Custer","year":"2025","journal-title":"Cureus"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4741.2006.00372.x","article-title":"Breast cancer metastasized to the scalp mimicking alopecia areata: Alopecia neoplastica","volume":"13","author":"Lin","year":"2007","journal-title":"Breast J"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/SMJ.0b013e31819b0c26","article-title":"Cutaneous metastasis of breast carcinoma presenting as alopecia neoplastica","volume":"102","author":"Conner","year":"2009","journal-title":"South Med J"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1159\/000063133","article-title":"Eyelid swelling: think of metastasis of histiocytoid breast carcinoma","volume":"205","author":"Tomasini","year":"2002","journal-title":"Dermatology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/1752-1947-5-428","article-title":"Metastatic breast carcinoma mimicking a sebaceous gland neoplasm: a case report","volume":"5","author":"M\u00fcller","year":"2011","journal-title":"J Med Case Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00106-007-1630-9","article-title":"Scalp metastasis of unrecognized breast cancer","volume":"55","author":"Prochno","year":"2007","journal-title":"Hno"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijwd.2018.08.002","article-title":"Scalp metastasis from occult primary breast carcinoma: A case report and review of the literature","volume":"4","author":"Alizadeh","year":"2018","journal-title":"Int J Womens Dermatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1159\/000484346","article-title":"Occult breast carcinoma presenting as scalp metastasis","volume":"10","author":"Costa","year":"2017","journal-title":"Case Rep Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s12254-019-0471-z","article-title":"Solitary scalp metastatic lesion as a sign of breast cancer recurrence\u2014a case report","volume":"12","author":"Abdelhafeez","year":"2019","journal-title":"memo - Magazine Eur Med Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1185","article-title":"FDA approval: palbociclib for the treatment of postmenopausal patients with estrogen receptor-positive, HER2-negative metastatic breast cancer","volume":"21","author":"Beaver","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.6155","article-title":"MONARCH 3: abemaciclib as initial therapy for advanced breast cancer","volume":"35","author":"Goetz","year":"2017","journal-title":"J Clin Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1093\/annonc\/mdz215","article-title":"Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer","volume":"30","author":"Hortobagyi","year":"2019","journal-title":"Ann Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01562-9","article-title":"Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial","volume":"27","author":"Xu","year":"2021","journal-title":"Nat Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1709244\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T05:13:07Z","timestamp":1765257187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1709244\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":29,"alternative-id":["10.3389\/fonc.2025.1709244"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1709244","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"article-number":"1709244"}}